|
 |
ZosynThis page contains recent news articles, when available, and an overview of Zosyn but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.In September, Orchid had announced getting a six-month exclusive window to sell generic Zosyn. It had forecast a 20% revenue growth in fiscal 2010 based on ... Livemint Venture Firms Jump Back Into Antibiotics, With Winning Results - Dec 28, 2009 Calixa elected to combine the drug with a generic antibiotic, tazobactam--which is also part of the marketed anti-infective, Zosyn--to give it broader ... Wall Street Journal Deals of the Week: Merry Chrismahanukwanzakah - Dec 18, 2009 This compound combines CXA-101, a novel cephalosporin, with tazobactam, a beta-lactamase inhibitor that is a component of Pfizer/Wyeth's antibiotic Zosyn. ... The IN VIVO Blog (blog) 3 cos sue Wyeth over Zosyn patent - Feb 3, 2007 Three generic pharmaceutical companies, including one from India, have taken legal action against US pharma major Wyeth. Their grouse is that Wyeth is ... Economic Times Article: 3 cos sue Wyeth over Zosyn patent. - Economic Times (New... - Feb 4, 2007 3 cos sue Wyeth over Zosyn patent. ... find Economic Times (New Delhi, India) articles. Feb. 4--Three generic pharmaceutical companies, including one from ... Pay-Per-View - Economic Times - HighBeam Research Wyeth Sees Effexor Growth Slowing - Apr 20, 2005 Sales of the antibiotic Zosyn gained 26% to $229 million for the first quarter. Zosyn is aimed at bacteria that have become resistant to other drugs, ... TheStreet.com - TheStreet.com (subscription) Wyeth Has 4th-Qtr Profit; Prevnar, Enbrel Sales Rise - Jan 31, 2006 Sales of the Zosyn antibiotic were also below his expectations. Anderson is one of StarMine ... Quarterly Zosyn sales were up 3 percent to $205 million. ... Bloomberg Wyeth at Bank of America Health Care Conference - Final. - May 31, 2007 Zosyn is our workhorse IV antibiotic. It's been on the market now for ... We had over $970 million of sales from Zosyn last year and just in the first ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com Hospira 3Q Earnings Slip, Shares Drop - Nov 8, 2006 Hospira is aiming for a generic version of Wyeth's Zosyn, which posted ... Begley said generic Zosyn is the largest drug in Hospira's 2007 pipeline but ... CNNMoney.com FINAL TRANSCRIPT - May 21, 2008 Okay, Zosyn - $1 billion business. What I said about Zosyn at the ... a new formulation which we call Zosyn EF. We have a citizen's petition with the FDA. ... $54.00 - Thomson StreetEvents - Alacra Store FDA to settle Citizen's Petitions against Wyeth - Feb 6, 2007 Wyeth explains that a new patent, a re-formulated version of Zosyn, ... Zosyn, an intravenous antibiotic for serious infections, recorded sales of more than ... In-PharmaTechnologist.com Wyeth Reports Results for the 2004 Fourth Quarter and Full Year; - … - Jan 31, 2005 Also contributing to Wyeth's growth in 2004 was ZOSYN. Zosyn remains the second largest selling and fastest growing broad-spectrum IV antibiotic globally. ... $4.95 - PR Newswire - ECNext Once-Daily IV Antibiotic Effective for Diabetic Foot Infections - Nov 10, 2005 11 - Invanz (ertapenem) is as effective as Zosyn (piperacillin/tazobactam) for diabetic foot infections but has the convenience of once-daily dosing, ... MedPage Today New York Miscellaneous Reports - DIRESTA v BRACKMAN, 3846-06 (4- … - Apr 24, 2008 Page 3 The plaintiff argues that Dr. LIPSKY's understanding as to the reason why Zosyn was given to the patient prior to Dr. Lipsky's consultation on ... Pay-Per-View - New York Miscellaneous Reports - Loislaw Event Brief of Q1 2007 Wyeth Earnings Conference Call - Final. - Apr 19, 2007 Enbrel, Prevnar, Zosyn, and nutritionals showed extremely strong growth. 6. ... Zosyn revenue has now reached the $1b mark in the latest 12-month period for ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com US hospitals use more antibiotics despite concerns - Nov 10, 2008 N Zosyn and the older drug vancomycin driving the trend, researchers said. ... Use of Wyeth's Zosyn, also called piperacillin-tazobactam, rose 84 percent ... Reuters Wyeth Reports Earnings Results for the 2005 Fourth Quarter and Full … - Jan 31, 2006 ZOSYN(R), a broad-spectrum IV antibiotic proven to help minimize the emergence of ... Over 15 million people have been treated with Zosyn since its launch, ... $4.95 - PR Newswire - ECNext Wyeth Reports Earnings Results for the 2005 Third Quarter and First... - Oct 21, 2005 ZOSYN(R), a broad-spectrum IV antibiotic proven to help minimize the ... Over 15 million people have been treated with Zosyn (sold outside the US as ... $4.95 - PR Newswire - ECNext Merck, Wyeth Sales Rise Little as Top Drugs Slow - Jan 31, 2006 He expected Effexor revenue of $875 million and Zosyn sales of $238 million. Wyeth said fourth-quarter sales of the Enbrel arthritis treatment outside North ... Bloomberg WYETH at SG Cowen & Co. 25th Annual Health Care Conference - … - Mar 15, 2005 Effexor, Protonix, Enbrel, Prevnar, and Zosyn showed very strong growth. ... This is a complement to Zosyn and it's forecast at $1 billion peak year sales. ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com Event Brief of Q3 2006 WYETH Earnings Conference Call - Part 1. - Oct 1, 2006 In the hospital business, Zosyn revenue was $245m, up 8% for 3Q06 and $723m, ... This performance reflects the allocations of shipments of Zosyn maintained ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com Wyeth's Tygacil antibiotic will be manufactured in Carolina plant - Jun 23, 2005 Tygacil, unlike Zosyn, is approved in a new class of antibiotics called glycylcyclines that overcome resistance to antibiotic use. ... Puerto Rico Herald Why Wyeth Shares May Be at Risk - Nov 12, 2007 As for generic Zosyn [an injectable anti-bacterial], Wyeth removed ... US Zosyn accounts for about 2% of estimated 2008 EPS assuming 28% sales decline. ... Subscription - Barron's Online - Dow Jones & Company Article: Wyeth sues Sandoz over generic - The Record (Bergen County, ... - May 30, 2008 Drugmaker Wyeth is suing the Food and Drug Administration to block the sale of a generic rival to its intravenous antibiotic Zosyn, claiming the generic is ... Pay-Per-View - The Record - HighBeam Research IDSA releases guidelines for the diagnosis and treatment of skin and... - Oct 1, 2006 ...(Unasyn) given intravenously or piperacillin/ 3.37 g every six to eight hours, tazobactam (Zosyn) given intravenously plus clindamycin 600 to 900 mg per ... Free with registration - American Family Physician - AccessMyLibrary.com Wyeth Reports Earnings Results for the 2008 Third Quarter and First... - Oct 22, 2008 Net revenue from EFFEXOR(R) and ZOSYN(R) also increased for the 2008 first nine months due primarily to price increases in the case of Effexor and increased ... Genetic Engineering News - Genetic Engineering News (press release) IDSA releases guidelines for the diagnosis and treatment of skin and... - Oct 1, 2006 ...(Unasyn) given intravenously or piperacillin/ 3.37 g every six to eight hours, tazobactam (Zosyn) given intravenously plus clindamycin 600 to 900 mg per ... $4.95 - American Family Physician - ECNext Analysis: Superbugs driving blockbusters. - Mar 7, 2007 Zosyn, which is given intravenously for nosocomial lower-respiratory-tract infections, is growing at a very strong rate that is expected to continue until ... Free with registration - UPI Health Business - AccessMyLibrary.com Wyeth at Lehman Brothers Ninth Annual Global Healthcare Conference - ... - Mar 9, 2006 A product like Zosyn, BeneFIX, Rapamune, BMP, all growing very strong ... Zosyn is the other major product that has patent expiration in the next few years. ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com Wyeth at Lehman Brothers 10th Annual Global Healthcare Conference - … - Mar 20, 2007 Down at the bottom you see products like Zosyn[R] didn't quite hit $1 billion but grew 9%. BeneFIX[R], a biotech product, BMP2, a biotech product, ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com Diagnosis and management of acute pyelonephritis in adults. - Mar 1, 2005 Every 6 to 8 hours -- (Zosyn) Ticarcillin-clavulanate Every 4 to 6 hours ... 3 g Piperacillin-tazobactam 3.375 g/4.5 g (Zosyn) Ticarcillin-clavulanate ... $4.95 - American Family Physician - ECNext Event Brief of Q1 2006 WYETH Earnings Conference Call - Part 2. - Apr 21, 2006 Ken, can you confirm that there is little to no of the older Zosyn product actually in the channel? And then second, can you make some comments -- you ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com Wyeth at Cowen and Company Annual Health Care Conference - Part 1. - Mar 13, 2007 Zosyn, just shy of a billion. Maybe we'll make that billion-dollar mark this year. With Zosyn, it's certainly off to a very good start in the first quarter. ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com Wyeth Earnings Jump on Higher Drug Sales | Article from AP Online | … - Apr 20, 2005 Sales were driven by the anti-depressant Effexor, the antibiotic Zosyn, and Enbrel, a treatment for ... Zosyn sales were $229 million, up 26 percent. ... Pay-Per-View - AP Online - HighBeam Research Soldiers Returning From Iraq May Be at Risk for Q Fever - Sep 27, 2006 The patient defervesced with 72 hours of Zosyn (piperacillin-tazobactam). He was discharged after eight days of Zosyn therapy and continued on a six-day ... MedPage Today Wyeth 3Q profit falls but meets forecasts - Oct 22, 2008 That revenue will be needed in part to offset future competition to Effexor and the antibiotic Zosyn from generics. Diversification is another key to ... FOXNews FDA Approves New Antibiotic From Wyeth - Jun 17, 2005 It also makes the Prevnar meningitis vaccine and the Zosyn antibiotic. Tygacil may have competition from Johnson & Johnson, which is developing the ... New York Times Hospitals use more antibiotics despite concerns - Nov 11, 2008 WASHINGTON (Reuters) - Use of antibiotics at US hospitals is rising despite concerns about fueling bacterial resistance, with Wyeth's Zosyn and the older ... Reuters India United States top 200 brand and generic drugs used in hospitals in … - Jun 19, 2006 Kytril 297192210.25 -10.55 64 Celebrex 291890383.49 -43.56 65 Zyvox 287399052.66 30.73 66 Ambien 286032840.33 14.99 67 Zosyn 285167605.28 1.40 68 Rebif ... $20.00 - Drug Topics - Alacra Store S&P Picks and Pans: RIMM, Schlumberger, Wyeth - Nov 28, 2008 ...offset generic erosion in three older drugs (Protonix, Effexor and Zosyn). We think Wyeth has one of the more robust pipelines in the big pharma group. ... BusinessWeek Wyeth may not launch depression drug until 2008 - Jan 30, 2007 The company also told analysts it does not expect a generic form of its antibiotic Zosyn to be launched in the United States until late 2007, if at all. ... Reuters Wyeth Maps Out Cost-Cutting Plan - Oct 21, 2005 Sales of Prevnar, a vaccine to prevent pneumococcal disease in infants and young children, advanced 23% to $393 million, and Zosyn, an intravenous ... TheStreet.com - TheStreet.com (subscription) Wyeth grows profit, but generics pose threat - Jan 31, 2008 Generic competition also is likely for Effexor and prescription antibiotic Zosyn, the company said. Shares slid 1.4 percent, to $39.15, in morning trading ... Bizjournals.com Wyeth Seen 'Finally Putting Fen-Phen Behind' - Feb 1, 2006 Reasons given for the slightly weaker-than-expected revenue were light sales of Effexor, Zosyn and Refacto, said Rubin. But these sales were partially ... Forbes Frank Tally; created antibiotics for Cubist - Oct 5, 2006 Dr. Tally then stepped away from academia, working at Lederle Labs in Pearl River, NY, where he helped develop antibiotics such as Zosyn . ... Boston Globe SPOTLIGHT: Study finds alarming spread of MRSA - Jun 25, 2007 As a result of this trend, antibacterial drugs--such as Pfizer's Zyvox and Wyeth's Zosyn--are being elevated to blockbuster status as this new generation of ... FierceBiotech A quarter to forget at Wyeth; shares fall | Article from The Record... - Feb 1, 2005 Sales rose for Enbrel, the antibiotic Zosyn, and the anti-pneumococcal vaccine Prevnar. The antidepressant Effexor, the company's leading product, ... Pay-Per-View - The Record - HighBeam Research Earlier misdeeds may curtail your ability to leave the US | Article... - Mar 25, 2007 LEDERLE ANTIBIOTIC WINS FDA APPROVAL By KEVIN G. DeMARRAIS, Staff ... antibiotics, as it gained federal approval to market Zosyn, the first new product of ... Pay-Per-View - The Record - HighBeam Research Wyeth reports 44 percent earnings rise for quarter | Article from The... - Apr 21, 2005 ...the rheumatoid arthritis treatment Enbrel, the vaccine Prevnar, which protects children against pneumococcal infections, and the antibiotic Zosyn. ... Pay-Per-View - The Record - HighBeam Research Fludarabine, cyclophosphamide and horse antithymocyte globulin … - Mar 6, 2006 First line cover consisted of piperacillin-tazobactam (Zosyn), amikacinteicoplanin (Targocid). Systemic antifungals were added if fever persisted for more ... Nature.com Advanced Life Sciences and Wyeth Sign Commercialization Agreement … - Oct 1, 2008 ..."If approved, we view cethromycin as an excellent addition to our strong portfolio of existing anti-infective agents, Tygacil(R) (tigecyline) and Zosyn(R) ... RedOrbit New way to fight bacteria wins | Article from The Record (Bergen... - Jun 17, 2005 He said Tygacil sales should help offset the impact of the expected 2007 patent expiration of Zosyn, another Wyeth antibiotic. ... Pay-Per-View - The Record - HighBeam Research 2007 Third Quarter Results - Oct 18, 2007 Prevnar, Enbrel, Nutrition products and Zosyn(R). Protonix(R) sales decreased 6% for the 2007 third quarter, reflecting lower inventory levels, ... Free with registration - PR Newswire - AccessMyLibrary.com Physicians Report MRSA "Superbug" Cases on the Rise, According to … - Jul 29, 2008 However, the recent 'black box' warning applied to quinolones for risk of Achilles tendon rupture may temper their use and pave the way for Zosyn to ... Genetic Engineering News - Genetic Engineering News (press release) MANY DRUG NAMES FAIL TO PASS FDA MUSTER PROCEDURE … - Mar 19, 2006 The other drugs were Zofran, an antinausea drug, and Zosyn, an antibiotic. Bob Lee, trademark counsel at Lilly, says he was surprised by the FDA's rejection ... Pay-Per-View - South Florida Sun - Sentinel - ProQuest Archiver The incorrigible bugs - Mar 30, 2008 Cefoperazone and sulbactam or piperacillin and tazobactam (marketed by Wyeth under the trade name Tazocin or Zosyn), and ticarcillin and clavulanic acid ... Express Pharma OBITUARIES-OTHER LOCATION-TALLY - Oct 3, 2006 In 1987, he left academia for the Lederle Labs, in Pearl River NY, where he was instrumental in developing antibiotics, including the widely used Zosyn. ... Pay-Per-View - Providence Journal - ProQuest Archiver Wyeth Reports Earnings Results for the 2007 Second Quarter and First ... - Jul 19, 2007 Enbrel (outside the US and Canada) 508 37% 953 35% Nutrition 358 19% 705 20% Alliance Revenue (1) 355 (1)% 659 8% Zosyn/Tazocin 280 17% 561 17% Premarin ... $4.95 - PR Newswire - ECNext Citi Initiates Coverage on Wyeth (WYE) with a Hold - Jul 18, 2008 We see upside to our estimates from limited US generic competition to Zosyn/EffexorXR. The uptake of Pristiq/Restilor & material pipeline setbacks ... StreetInsider.com - StreetInsider.com (subscription) Schaeffer's S&P 500 Index Hot Stocks Features Paychex, BMC Software, ... - Jun 28, 2005 The medications include Prevnar, a pneumonia vaccine for babies; Enbrel, a rheumatoid arthritis medication; and Zosyn, an antibiotic. ... businesswire.com A 52-Year-Old Man With a Low Bicarbonate Level - Jan 11, 2008 ...and a piperacillin and tazobactum injection (Zosyn). He received a 2-L normal saline bolus, and his systolic blood pressure improved to 90 mm Hg. ... Medscape Q3 2006 WYETH Earnings Conference Call - Final. - Oct 19, 2006 Turning to our small molecule pharmaceuticals, we have seen solid performance from our key brands, including Effexor, Protonix, Premarin and Zosyn. ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com (WYE) SqueezeTrigger Price is $46.967. There is $379,813,892.00 That ... - Oct 9, 2007 United States market only); anti-infectives, including ZOSYN (marketed as TAZOCIN internationally) and TYGACIL; vaccines, including PREVNAR (markete ... Free with registration - M2 Presswire - AccessMyLibrary.com Practice Guidelines - Apr 1, 2005 ...studies include ofloxacin (Floxin), piperacillin-tazobactam (Zosyn), levofloxacin (Levaquin), clindamycin (Cleocin), pexiganan, and linezolid (Zyvox). ... AAFP News Now Targanta taps Russo Partners - Sep 18, 2008 The company hired the agency based on its experience launching antibiotics, such as Zosyn. The work began September 1, said Susan Hager, ... PR Week - PRWeek Cubist Pharmaceuticals Statement on the Death of Dr. Francis P. Tally. - Oct 3, 2006 Prior to joining Cubist, Frank also played an important role in the development of three other antibiotics: Suprax, Zosyn, and what now has been introduced ... Free with registration - Business Wire - AccessMyLibrary.com Optimer Pharmaceuticals Appoints Kevin P. Poulos as Vice President of... - Aug 1, 2006 Beta-lactamase inhibitor combinations (Zosyn(R)/Tazocin(R), Timentin(R)), Streptogramins (Synercid(R)), Quinolones (Zagam(R), Penetrex(R)), and extended ... Genetic Engineering News - Genetic Engineering News (press release) A day in the life.(physician assistants)(Chronology) - Apr 1, 2007 It looks like pneumonia, so I start the patient on IV Zosyn (piperacillin/tazobactam), call respiratory therapy, and keep her on oxygen for now. ... Free with registration - JAAPA-Journal of the American Academy... - AccessMyLibrary.com Q4 2004 WYETH Earnings Conference Call - Part 1. - Jan 31, 2005 Effexor, Protonix, Enbrel, Prevnar and Zosyn showed strong growth in markets all around the world. Consumer healthcare and animal health also contributed to ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com Wyeth at Friedman Billings Ramsey 9th Annual Growth Conference - … - Jun 1, 2005 Zosyn, our injectable antibiotic, continued its strong performance, up solidly more than 20% in all markets around the world, up to $229 million in the ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com WYETH at UBS Global Life Sciences Conference - Final. - Sep 26, 2005 ...but we think that will improve actually throughout the course of the year; and Zosyn also becoming a very major product for us in the antibiotics field. ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com Wyeth Pharmaceuticals 2006 Analyst Meeting - Final. - Oct 5, 2006 We established a number of major product franchises that today lead their fields -- Effexor, Enbrel, Prevnar, Zosyn, to name just a few. ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com Fen-phem charges gouge Wyeth results.(Wyeth Pharmaceuticals) - Feb 7, 2005 ...(a pneumococcal disease vaccine), Enbrel (etanercept, for rheumatoid arthritis) and Zosyn (piperacillin and tazobactam, a combination antibiotic)." ... Free with registration - Pharma Marketletter - AccessMyLibrary.com (WYE) SqueezeTrigger Price is $46.959. There is $380,216,152.00 That ... - Oct 23, 2007 United States market only); anti-infectives, including ZOSYN (marketed as TAZOCIN internationally) and TYGACIL; vaccines, including PREVNAR (markete ... Free with registration - M2 Presswire - AccessMyLibrary.com Event Brief of Q4 2005 WYETH Earnings Conference Call - Part 1. - Jan 3, 2006 Certain other factors impacted the YonY comparisons including the significant level of Prevnar sales in 4Q04 and some product-availability issues with Zosyn ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com WYETH at Deutsche Bank Securities 31st Annual Health Care … - May 2, 2006 Our launched revenue up 30% at $250 million and then Zosyn benefits revenued in BMP was -- with modest growth and BMP in particular was very strong growth. ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com Q4 2005 Cubist Pharmaceuticals, Inc. Earnings Conference Call - Part... - Jan 2, 2006 This allows us to envision a long growth curve for Cubicin, such as that seen with Rocephin and Zosyn. I am quite confident that Cubicin will grow to a $500 ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com Event Brief of Q4 2005 Cubist Pharmaceuticals, Inc. Earnings Conferenc... - Jan 23, 2006 This allows the Co. to envision a long growth curve for CUBICIN, such as that seen with Rocephin and Zosyn. 12. CUBICIN is expected to grow to $500m drug in ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com Wyeth's 1st-qtr income up 12% to $1.25B.(Financial report) - Apr 30, 2007 ...the USA and Canada of $445.0 million, up 33%; and the intravenous antibiotic Zosyn (piperacillin/tazobactam) which contributed $281.0 million, up 18%. ... Free with registration - Pharma Marketletter - AccessMyLibrary.com Citizen Petition Reforms Under Revised PDUFA to Have Limited Impact - Sep 17, 2007 For example, Wyeth's injectable antibiotic Zosyn (piperacillin/tazobactam) reached blockbuster status earlier this year despite being off-patent. ... FDA news - FDA news (subscription) India top drug tweaker again - Aug 16, 2006 Aurobindo also filed for piperacillin, one of the active ingredients for Zosyn, which will also be expired in 2007. A few DMF submissions were done by ... Daily News & Analysis Fludrocortisone (Systemic). - Oct 27, 2005 Mezlin) Piperacillin (eg, Pipracil) or Piperacillin and tazobactam (eg, Zosyn) or Salicylates or Sirolimus (eg, Rapamune) or Sodium bicarbonate (eg, ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com Q4 2005 WYETH Earnings Conference Call - Part 1. - Jan 3, 2006 ...level of Prevnar sales in the fourth quarter of '04 and some product availability issues with Zosyn in late '05. These issues have since been corrected. ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com Wyeth's Slow Growth - Jan 30, 2007 By the end of 2008, key patents will have expired on its $1-billion-a-year antibiotic treatment Zosyn, $2-billion-a-year vaccine Prevnar, ... fool.com Event Brief of Q4 2005 WYETH Earnings Conference Call - Final. - Jan 31, 2006 Certain other factors impacted the YonY comparisons including the significant level of Prevnar sales in 4Q04 and some product-availability issues with Zosyn ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com NEWS | SAN DIEGO Promotions and Appointments - Aug 1, 2006 ...products such as Oxazolidinones (Zyvox), Beta-lactamase inhibitor combinations (Zosyn/Tazocin, Timentin), Streptogramins (Synercid), Quinolones (Zagam, ... San Diego Daily Transcript - San Diego Daily Transcript (subscription... Switzerland biotech: Arpida's shares sink 53% on negative review - Nov 19, 2008 ...was transferred to another hospital, where he was given Wyeth Pharmaceuticals Inc.'s injectable drug Zosyn (piperacillin-tazobactam) and azithromycin. ... $34.00 - EIU Country Analysis - Alacra Store Hospira earnings slip amid sales decline; shares slide - Nov 9, 2006 Specifically, Hospira Chief Executive Christopher B. Begley said Wyeth's reformulation of its antibiotic Zosyn will stop Hospira from reaching the market ... $2.95 - Southern Illinoisan - NewsBank Wyeth Reports Earnings Results for the 2006 Fourth Quarter and Full … - Jan 30, 2007 416.1 40% 1499.6 38% Alliance Revenue(1) 370.4 6% 1339.2 17% Nutritionals 306.7 20% 1200.8 15% Premarin Family 262.4 20% 1050.9 16% Zosyn/Tazocin 248.8 ... $4.95 - PR Newswire - ECNext Wyeth's Quarterly Net Drops 39% On Charges for Job Cuts, Taxes - Oct 22, 2005 Goldman Sachs analyst James Kelly attributed this to shortfalls in sales of Effexor, Enbrel and Zosyn, an intravenous antibiotic. ... Subscription - Wall Street Journal Online - Dow Jones & Company Wyeth drug to fight bacteria wins OK for use in hospitals. - Jun 18, 2005 He said Tygacil sales should help offset the impact of the expected 2007 patent expiration of Zosyn, another Wyeth antibiotic. ... $9.94 - Knight Ridder/Tribune Business News - Alacra Store Madison, NJ--Wyeth Pharmaceuticals reported net income and diluted … - Apr 27, 2005 Worldwide Pharmaceuticals net revenue increased 16 percent for the 2005 first quarter due primarily to higher sales of Prevnar, Enbrel, Effexor and Zosyn. ... $9.94 - Drug Store News-Newsfirst - Alacra Store Antibacterials Developer Mpex Inks Up To $32M In Series B Financing - Aug 12, 2005 CEO Gerhart used the examples of GlaxoSmithKline's Augmentin and Wyeth Pharmaceuticals Inc.'s Zosyn as other examples of combination-based antibacterials ... Subscription - VentureWire Alert - Dow Jones Financial Information Services Fitch Affirms Wyeth's 'A-/F2' Senior Unsecured & CP Ratings. - Jan 31, 2005 Wyeth's core pharmaceutical portfolio, including Protonix, Effexor, Prevnar, Enbrel, and Zosyn, continues to exhibit solid performance, demonstrated by ... $4.95 - Business Wire - ECNext Article: Generic Version of Plavix Blocked - AP Online | HighBeam … - Jun 19, 2007 Pharmaceuticals Ltd. of Chennai, India, from selling a generic version of Zosyn that the FDA approved last week. Wyeth's head ... the drugs in partnership ... Pay-Per-View - Associated Press/AP Online - HighBeam Research Press Release: Advanced Life Sciences and Wyeth Sign … - Oct 1, 2008 ..."If approved, we view cethromycin as an excellent addition to our strong portfolio of existing anti-infective agents, Tygacil(R) (tigecyline) and Zosyn(R) ... Pay-Per-View - PR Newswire - HighBeam Research Court to Hear Experimental Drugs Case | Article from AP Online | … - Nov 22, 2006 ...also does research on experimental drugs. It is one of India's top 15 pharmaceutical companies. The company has FDA approval to sell generic Zosyn ... ... Pay-Per-View - Associated Press/AP Online - HighBeam Research Patent Expiries of Leading Antibiotics From Several Pharmaceutical … - Jan 9, 2007 Merck's Primaxin, Abbott's Omnicef, AstraZeneca's Merrem, and Wyeth's Zosyn together generated more than $4 billion in sales in 2005. ... $4.95 - PR Newswire - ECNext Wyeth profit down due to staffing cuts and generic competition for... - Aug 4, 2008 ...up 6%; sales of the antibiotic Zosyn/Tazocin (piperacillin/tazobactam) were up 14% to $319.0 million; and overall turnover of menopause drug, ... $9.94 - Pharma Marketletter - Alacra Store FDA Proposes Broadening Access to Drugs | Article from AP Online | … - Dec 11, 2006 ...action ... and also does research on experimental drugs. It is one of India's top ... companies. The company has FDA approval to sell generic Zosyn ... ... Pay-Per-View - Associated Press/AP Online - HighBeam Research Do topical antibiotics improve wound healing?(CLINICAL INQUIRIES: … - Feb 1, 2007 ...benefit when topical piperacillin/tazobactam (not available in US as a topical agent) was added to parenteral piperacillin/tazobactam (Zosyn) alone. ... $4.95 - Journal of Family Practice - ECNext New treatment algorithm improves clinical outcomes in MRSA cases.( … - Dec 1, 2006 ...or clindamycin alone, or to administer intravenous clindamycin plus vancomycin or Zosyn (piperacillin sodium and tazobactam sodium) plus vancomycin. ... Pay-Per-View - Skin & Allergy News - Factiva, from Dow Jones (WYE) SqueezeTrigger Price is $46.970. There is $378,285,304.00 That ... - Oct 4, 2007 United States market only); anti-infectives, including ZOSYN (marketed as TAZOCIN internationally) and TYGACIL; vaccines, including PREVNAR (markete ... $4.95 - M2 Presswire - ECNext |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |